{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:54:38Z","timestamp":1762509278892,"version":"build-2065373602"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Pseudocellulitis, a non-infectious inflammatory reaction mimicking infectious cellulitis, is a rare and often underrecognized adverse reaction to pemetrexed, frequently diagnosed late and leading to inappropriate treatments, particularly unnecessary antibiotic use. Through the presentation of a new case and a literature review conducted using Scopus and PubMed, we aim to clarify its clinical presentation and management. We report a new case of pemetrexed-induced pseudocellulitis (PIP), initially misdiagnosed and treated unnecessarily with multiple antibiotics. Following the correct diagnosis, the patient was successfully treated with both oral and topical corticosteroids. Pemetrexed had to be discontinued. PIP clinically mimics cellulitis, presenting unilaterally or bilaterally, sometimes accompanied by fever and inflammatory syndrome. Its onset is variable, occurring either after the initial pemetrexed administration or following subsequent cycles, with no clear dose dependency. Skin biopsy is not essential for diagnosis. Management typically involves local and\/or systemic corticosteroids. Discontinuation of pemetrexed should be evaluated on a case-by-case basis and is not always necessary. Improved recognition of this condition is essential to avoid unnecessary interventions, enhance patient care, and prevent long-term complications due to prolonged inflammation.<\/jats:p>","DOI":"10.3389\/fonc.2025.1619250","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:17:56Z","timestamp":1759897076000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Pemetrexed-induced pseudocellulitis: a rare adverse effect to be recognized for better management"],"prefix":"10.3389","volume":"15","author":[{"given":"Emma","family":"Proux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Bonhomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Pottier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Piroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.10-6-363","article-title":"FDA drug approval summary: pemetrexed for injection (Alimta\u00ae) for the treatment of non-small cell lung cancer","volume":"10","author":"Cohen","year":"2005","journal-title":"Oncologist"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.982.11.3","article-title":"Pemetrexed in Malignant pleural mesothelioma","volume":"11","author":"Hazarika","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0761-8425(07)91133-X","article-title":"Toxicit\u00e9 cutan\u00e9e grave apr\u00e8s pemetrexed en traitement de deuxi\u00e8me ligne pour un cancer bronchique","volume":"24","author":"Tummino","year":"2007","journal-title":"Rev Mal Respir"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.163","article-title":"Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy","volume":"22","author":"Hanna","year":"2004","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14785","article-title":"Pseudocellulitis in the setting of pemetrexed treatment for non-small cell lung cancer","volume":"52","author":"Nguyen","year":"2025","journal-title":"J\u00a0Cutan Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52114","article-title":"Pemetrexed-induced pseudocellulitis: A diagnostic conundrum","volume":"16","author":"Horton","year":"2024","journal-title":"Cureus"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdcr.2023.05.011","article-title":"Edema of the face and extremities secondary to pemetrexed","volume-title":"JAAD Case Rep","author":"Doyle","year":"2023"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2023.04.016","article-title":"Pseudocellulitis in oncology patients: A single institutional retrospective analysis investigating the clinical presentation, therapeutic response, and implications for cancer therapy","volume":"12","author":"Pach","year":"2023","journal-title":"JAAD Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2020.06.016","article-title":"\u0152d\u00e8mes inflammatoires et scl\u00e9reux des membres inf\u00e9rieurs sous p\u00e9m\u00e9trexed","volume":"147","author":"Sarrazin","year":"2020","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12267","article-title":"Pemetrexed-induced pseudocellulitis","volume":"36","author":"Lo","year":"2020","journal-title":"Kaohsiung J Med Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13202","article-title":"Pemetrexed-induced lower limb pseudocellulitis","volume":"42","author":"Liau","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"B12","article-title":"Pemetrexed-induced pseudocellulitis - a rare cutaneous adverse reaction to mutl-targeted antifolate therapy","author":"Wollina","year":"2017","journal-title":"Georgian Med News"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2016.11.001","article-title":"Pemetrexed-induced eccrine squamous syringometaplasia manifesting as pseudocellulitis (in a patient with non\u2013small cell lung cancer)","volume":"3","author":"Santosa","year":"2017","journal-title":"JAAD Case Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000000645","article-title":"Pemetrexed-induced pseudocellulitis reaction with eosinophilic infiltrate on skin biopsy","volume":"39","author":"Tracey","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13354","article-title":"Pemetrexed-induced scleroderma-like conditions in the lower legs of a patient with non-small cell lung carcinoma","volume":"43","author":"Ishikawa","year":"2016","journal-title":"J Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2014.11.011","article-title":"Scl\u00e9rose cutan\u00e9e des deux membres inf\u00e9rieurs sous pemetrexed","volume":"142","author":"Corbaux","year":"2015","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000426","article-title":"Lipodermatosclerosis secondary to pemetrexed use","volume":"10","author":"Shuster","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2012.01.003","article-title":"Pemetrexed-induced skin sclerosis","volume":"24","author":"Merklen-Djafri","year":"2012","journal-title":"Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2012.10.529","article-title":"Une nouvelle toxicit\u00e9 \u00e0 ne pas m\u00e9conna\u00eetre : la scl\u00e9rose cutan\u00e9e algique induite par le pemetrexed (Alimta\u00ae)","volume":"139","author":"Salle De Chou","year":"2012","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/1078155212438453","article-title":"Pemetrexed-induced cellulitis: A rare toxicity in non-small cell lung cancer treatment","volume":"19","author":"Katsenos","year":"2013","journal-title":"J Oncol Pharm Pract"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318207f788","article-title":"A case series of dose-limiting peripheral edema observed in patients treated with pemetrexed","volume":"6","author":"D\u2019Angelo","year":"2011","journal-title":"J Thorac Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.01.003","article-title":"Painful generalized erythematous patches: A severe and unusual cutaneous reaction to pemetrexed","volume":"65","author":"Vitiello","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31822e722f","article-title":"Skin toxicities compromise prolonged pemetrexed treatment","volume":"6","author":"Eguia","year":"2011","journal-title":"J Thorac Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1097\/JTO.0b013e3182333f34","article-title":"Peripheral skin edema as unusual toxicity in three patients with advanced non-small cell lung cancer treated with pemetrexed alone or in combination with cisplatin","volume":"6","author":"Galetta","year":"2011","journal-title":"J Thorac Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2005.10.008","article-title":"Pemetrexed-associated urticarial vasculitis","volume":"51","author":"Lopes","year":"2006","journal-title":"Lung Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.31879\/rcderm.v36i2.319","article-title":"Pemetrexed-induced scleroderma-like lesions in a lung cancer patient","volume":"36","author":"S\u00e1nchez-Bernal","year":"2020","journal-title":"Rev Chil Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13354","article-title":"One case of scleroderma-like skin in bilateral calves induced by pemetrexed disodium for injection","volume":"20","author":"Liang","year":"2023","journal-title":"Chin J Pharmacovigilance"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/1078155215583523","article-title":"Single-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions","volume":"22","author":"Elsoueidi","year":"2016","journal-title":"J Oncol Pharm Pract"},{"key":"B29","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1001\/jamadermatol.2023.1735","article-title":"Chemotherapy-induced pseudocellulitis without prior radiation exposure: A systematic review","volume":"159","author":"Kovacs","year":"2023","journal-title":"JAMA Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.30","article-title":"Scleroderma-like cutaneous lesions induced by paclitaxel: A case study","volume":"48","author":"Kupfer","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.10.3426","article-title":"Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment","volume":"16","author":"Semb","year":"1998","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1619250\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T04:17:57Z","timestamp":1759897077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1619250\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":31,"alternative-id":["10.3389\/fonc.2025.1619250"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1619250","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"article-number":"1619250"}}